Global Hemostatic Agents Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Hemostatic Agents Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Hemostatic Agents Market Size Growth Rate by Type
  • 1.4.2 Gelation Sponge
  • 1.4.3 Oxidized Regenerated Cellulose Based Hemostats
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Hemostatic Agents Market Size Growth Rate by Application
  • 1.3.2 Hospitals
  • 1.3.3 Surgical Centers
  • 1.3.4 Nursing Homes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Hemostatic Agents Sales Estimates and Forecasts 2016-2027
• 2.2 Global Hemostatic Agents Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Hemostatic Agents Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Hemostatic Agents Regions by Sales
  • 2.4.1 Global Top Hemostatic Agents Regions by Sales (2016-2021)
  • 2.4.2 Global Top Hemostatic Agents Regions by Sales (2022-2027)
• 2.5 Global Top Hemostatic Agents Regions by Revenue
  • 2.5.1 Global Top Hemostatic Agents Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Hemostatic Agents Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Hemostatic Agents Sales by Manufacturers
  • 3.1.1 Global Top Hemostatic Agents Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Hemostatic Agents Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Hemostatic Agents Sales in 2020
• 3.2 Global Hemostatic Agents Revenue by Manufacturers
  • 3.2.1 Global Top Hemostatic Agents Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Hemostatic Agents Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Agents Revenue in 2020
• 3.3 Global Hemostatic Agents Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Hemostatic Agents Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Hemostatic Agents Sales by Type
  • 4.1.1 Global Hemostatic Agents Historical Sales by Type (2016-2021)
  • 4.1.2 Global Hemostatic Agents Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Hemostatic Agents Sales Market Share by Type (2016-2027)
• 4.2 Global Hemostatic Agents Revenue by Type
  • 4.2.1 Global Hemostatic Agents Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Hemostatic Agents Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Hemostatic Agents Revenue Market Share by Type (2016-2027)
• 4.3 Global Hemostatic Agents Price by Type
  • 4.3.1 Global Hemostatic Agents Price by Type (2016-2021)
  • 4.3.2 Global Hemostatic Agents Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Hemostatic Agents Sales by Application
  • 5.1.1 Global Hemostatic Agents Historical Sales by Application (2016-2021)
  • 5.1.2 Global Hemostatic Agents Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Hemostatic Agents Sales Market Share by Application (2016-2027)
• 5.2 Global Hemostatic Agents Revenue by Application
  • 5.2.1 Global Hemostatic Agents Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Hemostatic Agents Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Hemostatic Agents Revenue Market Share by Application (2016-2027)
• 5.3 Global Hemostatic Agents Price by Application
  • 5.3.1 Global Hemostatic Agents Price by Application (2016-2021)
  • 5.3.2 Global Hemostatic Agents Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Hemostatic Agents Market Size by Type
  • 6.1.1 North America Hemostatic Agents Sales by Type (2016-2027)
  • 6.1.2 North America Hemostatic Agents Revenue by Type (2016-2027)
• 6.2 North America Hemostatic Agents Market Size by Application
  • 6.2.1 North America Hemostatic Agents Sales by Application (2016-2027)
  • 6.2.2 North America Hemostatic Agents Revenue by Application (2016-2027)
• 6.3 North America Hemostatic Agents Market Size by Country
  • 6.3.1 North America Hemostatic Agents Sales by Country (2016-2027)
  • 6.3.2 North America Hemostatic Agents Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Hemostatic Agents Market Size by Type
  • 7.1.1 Europe Hemostatic Agents Sales by Type (2017-2027)
  • 7.1.2 Europe Hemostatic Agents Revenue by Type (2017-2027)
• 7.2 Europe Hemostatic Agents Market Size by Application
  • 7.2.1 Europe Hemostatic Agents Sales by Application (2017-2027)
  • 7.2.2 Europe Hemostatic Agents Revenue by Application (2017-2027)
• 7.3 Europe Hemostatic Agents Market Size by Country
  • 7.3.1 Europe Hemostatic Agents Sales by Country (2017-2027)
  • 7.3.2 Europe Hemostatic Agents Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Hemostatic Agents Market Size by Type
  • 8.1.1 Asia Pacific Hemostatic Agents Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Hemostatic Agents Revenue by Type (2018-2027)
• 8.2 Asia Pacific Hemostatic Agents Market Size by Application
  • 8.2.1 Asia Pacific Hemostatic Agents Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Hemostatic Agents Revenue by Application (2018-2027)
• 8.3 Asia Pacific Hemostatic Agents Market Size by Region
  • 8.3.1 Asia Pacific Hemostatic Agents Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Hemostatic Agents Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Hemostatic Agents Market Size by Type
  • 9.1.1 Latin America Hemostatic Agents Sales by Type (2019-2027)
  • 9.1.2 Latin America Hemostatic Agents Revenue by Type (2019-2027)
• 9.2 Latin America Hemostatic Agents Market Size by Application
  • 9.2.1 Latin America Hemostatic Agents Sales by Application (2019-2027)
  • 9.2.2 Latin America Hemostatic Agents Revenue by Application (2019-2027)
• 9.3 Latin America Hemostatic Agents Market Size by Country
  • 9.3.1 Latin America Hemostatic Agents Sales by Country (2019-2027)
  • 9.3.2 Latin America Hemostatic Agents Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Hemostatic Agents Market Size by Type
  • 6.1.1 Middle East and Africa Hemostatic Agents Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Hemostatic Agents Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Hemostatic Agents Market Size by Application
  • 6.2.1 Middle East and Africa Hemostatic Agents Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Hemostatic Agents Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Hemostatic Agents Market Size by Country
  • 6.3.1 Middle East and Africa Hemostatic Agents Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Hemostatic Agents Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Ethicon
  • 11.1.1 Ethicon Corporation Information
  • 11.1.2 Ethicon Overview
  • 11.1.3 Ethicon Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Ethicon Hemostatic Agents Product Description
  • 11.1.5 Ethicon Related Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Corporation Information
  • 11.2.2 Pfizer Overview
  • 11.2.3 Pfizer Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Pfizer Hemostatic Agents Product Description
  • 11.2.5 Pfizer Related Developments
• 11.3 Baxter International
  • 11.3.1 Baxter International Corporation Information
  • 11.3.2 Baxter International Overview
  • 11.3.3 Baxter International Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Baxter International Hemostatic Agents Product Description
  • 11.3.5 Baxter International Related Developments
• 11.4 C. R. Bard
  • 11.4.1 C. R. Bard Corporation Information
  • 11.4.2 C. R. Bard Overview
  • 11.4.3 C. R. Bard Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 C. R. Bard Hemostatic Agents Product Description
  • 11.4.5 C. R. Bard Related Developments
• 11.5 The Medicines Company
  • 11.5.1 The Medicines Company Corporation Information
  • 11.5.2 The Medicines Company Overview
  • 11.5.3 The Medicines Company Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 The Medicines Company Hemostatic Agents Product Description
  • 11.5.5 The Medicines Company Related Developments
• 11.6 Anika Therapeutics
  • 11.6.1 Anika Therapeutics Corporation Information
  • 11.6.2 Anika Therapeutics Overview
  • 11.6.3 Anika Therapeutics Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Anika Therapeutics Hemostatic Agents Product Description
  • 11.6.5 Anika Therapeutics Related Developments
• 11.7 Advanced Medical Solutions
  • 11.7.1 Advanced Medical Solutions Corporation Information
  • 11.7.2 Advanced Medical Solutions Overview
  • 11.7.3 Advanced Medical Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Advanced Medical Solutions Hemostatic Agents Product Description
  • 11.7.5 Advanced Medical Solutions Related Developments
• 11.8 Integra LifeSciences
  • 11.8.1 Integra LifeSciences Corporation Information
  • 11.8.2 Integra LifeSciences Overview
  • 11.8.3 Integra LifeSciences Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Integra LifeSciences Hemostatic Agents Product Description
  • 11.8.5 Integra LifeSciences Related Developments
• 11.9 B Braun Melsungen
  • 11.9.1 B Braun Melsungen Corporation Information
  • 11.9.2 B Braun Melsungen Overview
  • 11.9.3 B Braun Melsungen Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 B Braun Melsungen Hemostatic Agents Product Description
  • 11.9.5 B Braun Melsungen Related Developments
• 11.10 Gelita Medical
  • 11.10.1 Gelita Medical Corporation Information
  • 11.10.2 Gelita Medical Overview
  • 11.10.3 Gelita Medical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Gelita Medical Hemostatic Agents Product Description
  • 11.10.5 Gelita Medical Related Developments
• 11.1 Ethicon
  • 11.1.1 Ethicon Corporation Information
  • 11.1.2 Ethicon Overview
  • 11.1.3 Ethicon Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Ethicon Hemostatic Agents Product Description
  • 11.1.5 Ethicon Related Developments
• 11.12 Vascular Solutions
  • 11.12.1 Vascular Solutions Corporation Information
  • 11.12.2 Vascular Solutions Overview
  • 11.12.3 Vascular Solutions Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Vascular Solutions Product Description
  • 11.12.5 Vascular Solutions Related Developments
• 11.13 Marine Polymer Technologies
  • 11.13.1 Marine Polymer Technologies Corporation Information
  • 11.13.2 Marine Polymer Technologies Overview
  • 11.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Marine Polymer Technologies Product Description
  • 11.13.5 Marine Polymer Technologies Related Developments
• 11.14 Z-Medica
  • 11.14.1 Z-Medica Corporation Information
  • 11.14.2 Z-Medica Overview
  • 11.14.3 Z-Medica Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Z-Medica Product Description
  • 11.14.5 Z-Medica Related Developments
• 11.15 CryoLife
  • 11.15.1 CryoLife Corporation Information
  • 11.15.2 CryoLife Overview
  • 11.15.3 CryoLife Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 CryoLife Product Description
  • 11.15.5 CryoLife Related Developments
• 11.16 BioCer Entwicklungs
  • 11.16.1 BioCer Entwicklungs Corporation Information
  • 11.16.2 BioCer Entwicklungs Overview
  • 11.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 BioCer Entwicklungs Product Description
  • 11.16.5 BioCer Entwicklungs Related Developments
• 11.17 Biom’Up SAS
  • 11.17.1 Biom’Up SAS Corporation Information
  • 11.17.2 Biom’Up SAS Overview
  • 11.17.3 Biom’Up SAS Hemostatic Agents Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Biom’Up SAS Product Description
  • 11.17.5 Biom’Up SAS Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Hemostatic Agents Value Chain Analysis
• 12.2 Hemostatic Agents Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Hemostatic Agents Production Mode & Process
• 12.4 Hemostatic Agents Sales and Marketing
  • 12.4.1 Hemostatic Agents Sales Channels
  • 12.4.2 Hemostatic Agents Distributors
• 12.5 Hemostatic Agents Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Hemostatic Agents Industry Trends
• 13.2 Hemostatic Agents Market Drivers
• 13.3 Hemostatic Agents Market Challenges
• 13.4 Hemostatic Agents Market Restraints

14 Key Findings in The Global Hemostatic Agents Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details